Plant stanols and sterols of the 4-desmethyl family (e.g., sitostanol and sitosterol) effectively decrease LDL cholesterol concentrations, whereas 4,4-dimethylsterols ( ␣ -amyrin and lupeol) do not. Serum carotenoid concentrations, however, are decreased by both plant sterol families. The exact mechanisms underlying these effects are not known, although effects on micellar composition have been suggested. With a liver X receptor (LXR) coactivator peptide recruitment assay, we showed that plant sterols and stanols from the 4-desmethylsterol family activated both LXR ␣ and LXR  , whereas 4,4-dimethyl plant sterols did not. In fully differentiated Caco-2 cells, the functionality of Foods enriched with plant stanol or sterol esters (socalled functional foods) have gained a prominent position in decreasing cardiovascular risk by dietary means (1). Indeed, numerous intervention trials have demonstrated that plant stanol/sterol esters consistently and dosedependently decrease serum LDL cholesterol concentrations in various populations and patient groups (2). The mechanism underlying this hypocholesterolemic effect is a reduction in cholesterol absorption from the intestinal lumen into the circulation, as explained through a competition between plant stanols/sterols and intestinal cholesterol for incorporation into mixed micelles (3). Whether this is indeed the main or the only mechanism is still unknown. In this respect, we earlier suggested that sitostanol may affect cholesterol metabolism within intestinal cells (4). Cellular cholesterol concentrations within enterocytes are determined by several routes, such as cholesterol uptake from the lumen as mediated by Niemann-Pick C1-like 1 and/or annexin 2/caveolin 1 complexes (5, 6); however, the role of caveolin 1 in this process has recently been questioned (7). Besides by changing uptake, cellular cholesterol levels can also be regulated by cholesterol secretion back into the intestinal lumen by ATP binding cassette (ABC) transporters. In a series of elegant experiments, Yu and coworkers (8-10) have shown that ABCG5 and ABCG8 are involved in the liver X receptor (LXR) agonist-induced reduction of intestinal cholesterol absorption. Thus, it is possible that cholesterol metabolism within the enterocyte may change as a result of LXR agonist activity of plant stanols or sterols or one of their (oxidized) metabolites. To have any effects within the enterocyte, however, it is necessary that these components are taken up by enterocytes, as has been demonstrated (11).Plant stanols/sterols decrease not only serum LDL cholesterol concentrations but also serum hydrocarbon carotenoid (i.e., ␣ -ϩ  -carotene and lycopene) concentrations. This reduction persisted after standardization for serum lipid concentrations, which indicated that this decrease is not attributable simply to a decreased number of LDL particles, a main carrier of the plasma carotenoids (12). Indeed, we have already shown that this reduction is significantly associated with the reduction of cholesterol a...